PERSPECTA

News from every angle

← Back to headlines

Enliven Therapeutics Prices Upsized $400M Public Offering

Enliven Therapeutics has priced an upsized $400 million public offering, consisting of common stock and pre-funded warrants.

12 Jun, 04:51 — 12 Jun, 04:51
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed4h ago

Enliven Therapeutics prices upsized $400M public offering of common stock and pre-funded warrants

Read full article →

Related Stories

Oil Jumps Above $100 After US-Iran Talks Fail

just now

AI Token Prices Expected to Plummet Following New Technology Wave

46m ago

Americans' Financial Future Increasingly Tied to AI Following Major IPOs

47m ago

SpaceX Makes Historic Stock Market Debut with $1.77 Trillion Valuation

47m ago